Primary axillary hyperhidrosis Primary focal hyperhidrosis,
Conditions
Interventions
apply approximately 1 fingertip unit of the lotion
from the unlabeled bottles of 3-
mm nozzle on one side of axilla, apply approximately 1 fingertip unit of the lotion
from the unlabeled bottles of 3-
mm nozzle on another side of axilla
Experimental Drug,Experimental Drug
20% aluminum sesquichlorohydrate, 20% aluminum chloride
Sponsors
Faculty of Medicine, Srinakharinwirot University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The participants were 18 to 60 years of age with Sweating Intensity Visual Scale (SIVS)by iodine-starch testof 2 or higher, and HDSS of grade 2 or higher for at least 6 months.
Exclusion criteria
Exclusion criteria: d history of allergy or sensitivity to aluminum salts, previous axillary treatments with topical antiperspirant or anticholinergic medication within 2 weeks of the trial, treatment with energy-based device in axillae within 6 months, treatment with botulinum toxin A or iontophoresis within 12 months, and active skin diseases, for example, dermatological infections or eczema in the treatment area. Use of OTC antiperspirant products were advised to be stopped 24 hours prior to the day of screening, and during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sweating Intensity Visual Scale (SIVS) Baseline, week1, week2, week4, week6 and week8 Iodine-starch test photography | — |
Secondary
| Measure | Time frame |
|---|---|
| Hyperhidrosis Disease Severity Score (HDSS) Baseline, week1, week2, week4, week6 and week8 disease-specific scale for hyperhidrosis | — |
Countries
Thailand
Contacts
Public ContactThianthong Thianboonsong
Skin center, Srinakharinwirot University
Outcome results
None listed